Vitae Pharmaceuticals Reports First Quarter 2015 Operating and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/16/2026
- Wall St ends higher on cool inflation data, strong earnings
- U.S. headline producer inflation posts first one-month decrease since August 2025
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
- Oil prices make small gain on smaller US inventory draw
- ASML capacity upgrade soothes AI chip bottleneck fears
Vitae Pharmaceuticals (VTAE) Misses Q1 EPS by 12c
May 12, 2015 4:53 PM EDTVitae Pharmaceuticals (NASDAQ: VTAE) reported Q1 EPS of ($0.47), $0.12 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $150.24 thousand versus the consensus estimate of $90 thousand.
As of March 31, 2015, Vitae had $88.7 million in cash, cash equivalents and marketable securities, compared to $65.3... More
